$64.665
-0.621 (-0.96%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BMRN por análisis de gráficos similares
Alphio's BMRN stock price prediction model matches the current BioMarin Pharmaceutical Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $63.59 (-1.67%). The 1-week path is $62.34 (-3.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc appears to be a good buy at the current price of $64.665, especially considering its strong revenue growth, with Q2 2026 revenue reported at $989.7 million, a 20% increase year-over-year. Additionally, the forward P/E ratio of 13.23 suggests the stock is undervalued compared to its earnings potential. The main risk is the recent increase in debt to equity, which rose to 66.22% in Q2 2026, indicating potential financial strain.
BMRN cerró en $64.67 el Friday, tras bajar -0.96%
BioMarin Pharmaceutical Inc. (BMRN) last closed at $64.665, losing -0.96%. These facts feed the 1-day and 1-week BMRN price prediction above.
Consenso de analistas
BioMarin Pharmaceutical Inc. (BMRN): 19 comprar, 5 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de BioMarin Pharmaceutical Inc. (BMRN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BMRN, ordenadas por similitud.
Análisis de estacionalidad de BMRN
Historically the probability of a positive August return for BMRN is 31.75%. March offers the highest probability of a positive month at 44.44%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BMRN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $72.19 | $79.24 | $81.50 | +22.54% |
| Sep 2026 | $49.01 | $64.04 | $73.58 | -0.96% |
| Oct 2026 | $56.29 | $58.23 | $68.61 | -9.95% |
| Nov 2026 | $71.73 | $79.24 | $84.14 | +22.54% |
| Dec 2026 | $59.93 | $67.88 | $73.71 | +4.97% |
En 2026, se proyecta que BioMarin Pharmaceutical Inc. (BMRN) oscile entre $49.01 y $84.14.
Previsión mensual de BioMarin Pharmaceutical Inc. para 2026
En Aug de 2026, se proyecta que BioMarin Pharmaceutical Inc. promedie $79.24, con un mínimo de $72.19 y un máximo de $81.50.
En Sep de 2026, se proyecta que BioMarin Pharmaceutical Inc. promedie $64.04, con un mínimo de $49.01 y un máximo de $73.58.
En Oct de 2026, se proyecta que BioMarin Pharmaceutical Inc. promedie $58.23, con un mínimo de $56.29 y un máximo de $68.61.
En Nov de 2026, se proyecta que BioMarin Pharmaceutical Inc. promedie $79.24, con un mínimo de $71.73 y un máximo de $84.14.
En Dec de 2026, se proyecta que BioMarin Pharmaceutical Inc. promedie $67.88, con un mínimo de $59.93 y un máximo de $73.71.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.